Parke-Davis Professor of Pharmaceutical Sciences Co-Director, Center for Drug Delivery and Nanomedicine Director, COBRE Nebraska Center for Nanomedicine University of Nebraska Medical Center
Overview: This COBRE has been funded to create the Nebraska Center for Nanomedicine (NCN), a Center of Biomedical Research Excellence (COBRE). Nanomedicine is a rapidly developing area of biomedical research that uses devices of nanoscale size to address urgent needs for improved drug and gene delivery. Such "next generation" therapies can specifically deliver drugs and recombinant DNAs to focal areas of disease or to tumors to maximize clinical benefit while limiting untoward side effects. Such nanotechnologies are expected to drastically improve early diagnosis through bioimaging techniques. This parallels the road map for the National Institutes of Health (NIH) where nanomedicine was identified as a development initiative for the next decade. In keeping with these ideas, the Center will serve to join already strong areas of biomedical and material science research into an even stronger unit. Such goals can now be realized with the established expertise in biomedical sciences (neuroscience, pathology, immunology, pharmacology, immunization and cancer biology) and those in the material sciences (nanomaterials, polymers, drug delivery, and gene delivery) within the University of Nebraska Medical Center (UNMC).
Mission: The primary goal of this COBRE is to provide a foundation for synergistic research activities and translating the efforts into clinical benefit for diseases with limited treatment options while simultaneously developing a potentially "visionary" area of science where the State of Nebraska can emerge as a world-leader.
The COBRE Nebraska Center for Nanomedicine is supported by the National Institute of General Medical Science (NIGMS) grants 4P20GM103480-10 and1P30 GM127200-01.